tradingkey.logo

Amgen Q1 Adjusted EPS $4.90 Vs IBES Estimate $4.30

ReutersMay 1, 2025 10:26 PM

- Amgen Inc AMGN.O:

  • AMGEN Q1 ADJUSTED EPS $4.90 VERSUS IBES ESTIMATE $4.30

  • AMGEN Q1 TOTAL REVENUE $8.15 BILLION VERSUS IBES ESTIMATE $8.06 BILLION

  • AMGEN OUTLOOK FY TOTAL REVENUE $34.3 BILLION TO $35.7 BILLION VERSUS IBES ESTIMATE $35.09 BILLION

  • AMGEN: 2025 SHARE REPURCHASES NOT TO EXCEED $500 MILLION

  • AMGEN: 2025 OUTLOOK INCLUDES ESTIMATED IMPACT OF IMPLEMENTED TARIFFS, BUT DOES NOT ACCOUNT FOR ANY FUTURE LEVIES

  • AMGEN OUTLOOK FY ADJUSTED EPS $20.00 TO $21.20 VERSUS IBES ESTIMATE $20.64

  • AMGEN: PHASE 1 STUDY OF AMG 513 ENROLLING PEOPLE LIVING WITH OBESITY AFTER REMOVAL OF CLINICAL HOLD BY U.S. FDA

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI